ClinicalTrials.Veeva

Menu

Validation of a CREATION Health Assessment Tool for Patients in a Diabetic Outpatient Population (CHAT-P)

AdventHealth logo

AdventHealth

Status

Completed

Conditions

Type 2 Diabetes Mellitus

Treatments

Other: CHAT-P

Study type

Observational

Funder types

Other

Identifiers

NCT03686917
1304646

Details and patient eligibility

About

Participants will complete a survey before an educational session, during the "break" of an educational session, or after the session.

Full description

Participants will be recruited from diabetes education sessions at selected locations and at FHMG physician practices. For the diabetes education setting, ta research team member will introduce this study to a group of patients before educational sessions, during "break" of the educational sessions, and after sessions. If the patient is interested, an envelope with the Invitation to Participant letter attached to it and the survey enclosed will be given to them. Also, a NOTE will be attached to the envelope with the instructions: "Please drop your completed survey in the drop-box at ___." The drop-box location will be identified within each setting and provided to the participants in the note or indicated verbally.

For patients at physician practices, an envelope with the Invitation to Participant letter attached to it and survey enclosed will be given by a staff member. Invitation to Participant letter contains all portions of the consent process. A NOTE will be attached to the envelope with the instructions: "Please drop your completed survey in the drop box at____." The drop-box location will be identified within each setting and provided to the participants in the note or indicated verbally. If patient does not meet the inclusion criteria, they will be asked to return the envelope to the staff member who provided it.

Patients will be provided with Invitation to Participate letter along with survey. The Invitation to Participate letter provides patients with study details including inclusion/exclusion criteria, duration of participation, procedures to ensure confidentiality, and an overview of voluntary participation conditions. Implied consent will be used. In addition to the Invitation to Participate letter, there is a statement at the top of the survey "return of completed surveys implies consent to participate in the study"

Enrollment

260 patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18 and above
  2. Diagnosis of type II diabetes
  3. Able to speak and understand English
  4. Able to provide informed consent

Exclusion criteria

  1. Children under 18
  2. Does not speak or understand English
  3. Not of cognitive capacity to provide valid responses
  4. Prisoners

Trial design

260 participants in 1 patient group

CHAT-P
Description:
Survey
Treatment:
Other: CHAT-P

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems